Canada markets closed

CRISPR Therapeutics AG (1CG.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
40.800.00 (0.00%)
At close: 08:10AM CEST
Show:
Income Statement
Cash Flow
Annual

Balance Sheet

All numbers in thousands
Breakdown
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Assets
Current Assets
Cash
Cash And Cash Equivalents
389,477
211,885
923,031
1,168,620
Other Short Term Investments
1,304,215
1,603,433
1,456,098
521,713
Total Cash
1,693,692
1,815,318
2,379,129
1,690,333
Net Receivables
200,000
0
305
144
Other Current Assets
14,386
37,708
38,079
-
Total Current Assets
1,908,078
1,853,026
2,417,513
1,716,620
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
359,371
354,387
349,842
114,200
Accumulated Depreciation
-53,433
-33,832
-37,807
-21,175
Net property, plant and equipment
305,938
320,555
312,035
93,025
Equity and other investments
1,973
53,130
0
-
Other long-term assets
13,566
16,275
22,204
18,141
Total non-current assets
321,493
390,031
334,364
111,346
Total Assets
2,229,571
2,243,057
2,751,877
1,827,966
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Accounts Payable
38,147
27,428
14,816
9,094
Accrued liabilities
45,335
77,682
91,003
53,782
Deferred revenues
4,105
0
1,011
2,341
Other Current Liabilities
5,141
20
171
7,207
Total Current Liabilities
108,791
121,107
119,883
94,259
Non-current liabilities
Deferred revenues
14,012
12,323
12,323
11,776
Other long-term liabilities
958
5,969
7,339
7,630
Total non-current liabilities
237,977
246,471
232,534
69,473
Total Liabilities
346,768
367,578
352,417
163,732
Stockholders' Equity
Common Stock
2,497
2,441
2,391
2,277
Retained Earnings
-999,700
-846,090
-195,915
-573,576
Accumulated other comprehensive income
1,913
-15,647
-5,067
-83
Total stockholders' equity
1,882,803
1,875,479
2,399,460
1,664,234
Total liabilities and stockholders' equity
2,229,571
2,243,057
2,751,877
1,827,966